Blade Q1 net loss narrows to $4.2M; Medical revenue record $36M, up 34.6% YoY

Strata Critical Medical, Inc.

2024-Q1 EPS reported -$0.06 revenue$51,514,000

Total Q1 revenue of $51.5M, up 13.8% YoY; Medical segment revenue hit a record $36.0M.
Net loss improved to ($4.2M) from ($10.2M) a year ago; Adjusted EBITDA loss narrowed to ($3.5M).
Medical Segment Adjusted EBITDA reached $4.4M (+134.5%); Passenger EBITDA loss improved to ($2.7M).
Company reaffirms FY 2024 Adjusted EBITDA profitability and double-digit millions target for 2025.
Gross profit margin expanded to 11.4% from 7.1%, driven by higher-margin Medical revenue.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Strata Critical Medical, Inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).

Period: the first quarter ended March 31, 2024
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On May 7, 2024, Blade Air Mobility, Inc. (“Blade”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.

View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001779128-24-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.